Latest Articles

Publication Date
Study: Women with severe endometriosis 10 times more likely to get ovarian cancer - News-Medical.Net

Study: Women with severe endometriosis 10 times more likely to get ovarian cancer News-Medical.Net

Published: July 18, 2024, 7 a.m.
Women with endometriosis face ‘markedly increased’ risk of ovarian cancer, study suggests - Forbes Australia

Women with endometriosis face ‘markedly increased’ risk of ovarian cancer, study suggests Forbes Australia

Published: July 18, 2024, 7 a.m.
Women with endometriosis face fourfold higher risk of ovarian cancer, study suggests - CNN

Women with endometriosis face fourfold higher risk of ovarian cancer, study suggests CNN

Published: July 17, 2024, 7 a.m.
Women With Endometriosis Face ‘Markedly Increased’ Risk Of Ovarian Cancer, Study Suggests - Forbes

Women With Endometriosis Face ‘Markedly Increased’ Risk Of Ovarian Cancer, Study Suggests Forbes

Published: July 17, 2024, 7 a.m.
Mimics of primary ovarian cancer and primary peritoneal carcinomatosis - A pictorial review.

Numerous conditions can mimic ovarian malignancy. Identifying the origin of a pelvic mass or disseminated peritoneal abnormality on imaging is important to ensure that the patient receives optimal management by …

Published: July 9, 2024, midnight
FDA grants breakthrough designation for ovarian cancer liquid biopsy - TechTarget

FDA grants breakthrough designation for ovarian cancer liquid biopsy TechTarget

Published: May 31, 2024, 7 a.m.
For some endometriosis-related ovarian cancers, timing is everything - Medical Xpress

For some endometriosis-related ovarian cancers, timing is everything Medical Xpress

Published: May 28, 2024, 7 a.m.
Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk - Medpage Today

Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk Medpage Today

Published: May 24, 2024, 7 a.m.
Mayo scientists explore swabs for early endometrial, ovarian cancer detection - Mayo Clinic

Mayo scientists explore swabs for early endometrial, ovarian cancer detection Mayo Clinic

Published: May 23, 2024, 7 a.m.
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewswire

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous …

Published: May 20, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!